Incyte Market Cap

Incyte has a market cap or net worth of $24.54 billion as of October 30, 2026. It is the 995th most valuable company in the world and the 422nd biggest in the United States. Its market cap has increased by 38.61% in one year.

Market Cap

24.54B

Enterprise Value

20.72B

1-Year Change

38.61%

Global Rank

#995

Country Rank

#422 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Incyte's market cap has increased from $887.90M to $24.54B, an increase of 2,663.76%. That is a compound annual growth rate of 12.62%.

Market Cap History

Date	Market Cap	% Change
Oct 30, 2026	24.54B	26.55%
Dec 31, 2025	19.39B	45.73%
Dec 31, 2024	13.31B	-5.44%
Dec 29, 2023	14.07B	-21.25%
Dec 30, 2022	17.87B	10.21%
Dec 31, 2021	16.21B	-14.88%
Dec 31, 2020	19.05B	1.27%
Dec 31, 2019	18.81B	38.99%
Dec 31, 2018	13.53B	-32.29%
Dec 29, 2017	19.99B	5.81%
Dec 30, 2016	18.89B	-6.36%
Dec 31, 2015	20.17B	63.32%
Dec 31, 2014	12.35B	51.41%
Dec 31, 2013	8.16B	274.30%
Dec 31, 2012	2.18B	14.96%
Dec 30, 2011	1.90B	-7.01%
Dec 31, 2010	2.04B	88.80%
Dec 31, 2009	1.08B	193.21%
Dec 31, 2008	368.30M	-56.50%
Dec 31, 2007	846.70M	72.90%
Dec 29, 2006	489.70M	9.92%
Dec 30, 2005	445.50M	-39.62%
Dec 31, 2004	737.80M	48.87%
Dec 31, 2003	495.60M	59.97%
Dec 31, 2002	309.80M	-76.00%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Revolution Medicines	40.39B
Royalty Pharma	38.74B
Genmab	35.11B
Roivant Sciences	26.59B
Insmed	24.70B
Alnylam Pharmaceuticals	22.36B
BioNTech SE	22.04B
Exelixis	17.46B

Market Cap Rankings